Literature DB >> 20029424

A census of amplified and overexpressed human cancer genes.

Thomas Santarius1, Janet Shipley, Daniel Brewer, Michael R Stratton, Colin S Cooper.   

Abstract

Integrated genome-wide screens of DNA copy number and gene expression in human cancers have accelerated the rate of discovery of amplified and overexpressed genes. However, the biological importance of most of the genes identified in such studies remains unclear. In this Analysis, we propose a weight-of-evidence based classification system for identifying individual genes in amplified regions that are selected for during tumour development. In a census of the published literature we have identified 77 genes for which there is good evidence of involvement in the development of human cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20029424     DOI: 10.1038/nrc2771

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  32 in total

1.  Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1.

Authors:  S Rodriguez; O Jafer; H Goker; B M Summersgill; G Zafarana; A J M Gillis; R J H L M van Gurp; J W Oosterhuis; Y-J Lu; R Huddart; C S Cooper; J Clark; L H J Looijenga; J M Shipley
Journal:  Oncogene       Date:  2003-03-27       Impact factor: 9.867

2.  Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.

Authors:  Véronique Bourdon; Félix Naef; Pulivarthi H Rao; Victor Reuter; Samuel C Mok; George J Bosl; Sanjay Koul; Vundaralli V V S Murty; Raju S Kucherlapati; R S K Chaganti
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

3.  Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.

Authors:  Graham R Bignell; Thomas Santarius; Jessica C M Pole; Adam P Butler; Janet Perry; Erin Pleasance; Chris Greenman; Andrew Menzies; Sheila Taylor; Sarah Edkins; Peter Campbell; Michael Quail; Bob Plumb; Lucy Matthews; Kirsten McLay; Paul A W Edwards; Jane Rogers; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Genome Res       Date:  2007-08-03       Impact factor: 9.043

4.  No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas.

Authors:  Katleen De Preter; Frank Speleman; Valérie Combaret; John Lunec; Julian Board; Andy Pearson; Anne De Paepe; Nadine Van Roy; Geneviève Laureys; Jo Vandesompele
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

5.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Authors:  Charles L Vogel; Melody A Cobleigh; Debu Tripathy; John C Gutheil; Lyndsay N Harris; Louis Fehrenbacher; Dennis J Slamon; Maureen Murphy; William F Novotny; Michael Burchmore; Steven Shak; Stanford J Stewart; Michael Press
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

6.  Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.

Authors:  Setsuko Kaneko; Miki Ohira; Yohko Nakamura; Eriko Isogai; Akira Nakagawara; Michio Kaneko
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-07       Impact factor: 4.553

Review 7.  Amplification of oncogenes revisited: from expression profiling to clinical application.

Authors:  L Savelyeva; M Schwab
Journal:  Cancer Lett       Date:  2001-06-26       Impact factor: 8.679

Review 8.  Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

Authors:  Christopher J Ormandy; Elizabeth A Musgrove; Rina Hui; Roger J Daly; Robert L Sutherland
Journal:  Breast Cancer Res Treat       Date:  2003-04       Impact factor: 4.872

9.  Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

Authors:  Axel Weber; Patricia Imisch; Eckhard Bergmann; Holger Christiansen
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

10.  FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.

Authors:  Jorge Sergio Reis-Filho; Pete T Simpson; Nicholas C Turner; Maryou Ballo Lambros; Chris Jones; Alan Mackay; Anita Grigoriadis; David Sarrio; Kay Savage; Tim Dexter; Marjan Iravani; Kerry Fenwick; Barbara Weber; David Hardisson; Fernando Carlos Schmitt; Jose Palacios; Sunil R Lakhani; Alan Ashworth
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

View more
  269 in total

1.  Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers.

Authors:  Srikant Ambatipudi; Moritz Gerstung; Manishkumar Pandey; Tanuja Samant; Asawari Patil; Shubhada Kane; Rajiv S Desai; Alejandro A Schäffer; Niko Beerenwinkel; Manoj B Mahimkar
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

2.  Combinatorics of the breakage-fusion-bridge mechanism.

Authors:  Marcus Kinsella; Vineet Bafna
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

Review 3.  Gene overexpression: uses, mechanisms, and interpretation.

Authors:  Gregory Prelich
Journal:  Genetics       Date:  2012-03       Impact factor: 4.562

Review 4.  Medulloblastoma-biology and microenvironment: a review.

Authors:  Tiara Byrd; Robert G Grossman; Nabil Ahmed
Journal:  Pediatr Hematol Oncol       Date:  2012-06-28       Impact factor: 1.969

5.  Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Authors:  Jiang-Jiang Qin; Wei Wang; Sushanta Sarkar; Ruiwen Zhang
Journal:  J Control Release       Date:  2016-07-06       Impact factor: 9.776

6.  Cancer progression modeling using static sample data.

Authors:  Yijun Sun; Jin Yao; Norma J Nowak; Steve Goodison
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

7.  Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation.

Authors:  Baltazar D Aguda; Yangjin Kim; Hong Sug Kim; Avner Friedman; Howard A Fine
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

8.  Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicity.

Authors:  Yinfei Tan; Eleonora Sementino; Jonathan Chernoff; Joseph R Testa
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 9.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

10.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.